FDA commissioner
Jump to navigation
Jump to search
Introduction
Dr. Scott Gottlieb confirmed May 10, 2017 by U.S. Senate & resigned effective April 5, 2019.
Dr. Norman Sharpless, the director of the National Cancer Institute (NCI), will step in as acting commissioner of the FDA when Dr. Scott Gottlieb leaves in April, 2019,[3]
Dr. Stephen Hahn confirmed as the new commissioner of the FDA Dec 2019[4]
Robert M. Califf, M.D was named FDA commissioner on Feb 17, 2022
Additional terms
References
- ↑ United States Senate Roll Call Vote 115th Congress - 1st Session. May 9, 2017 https://www.senate.gov/legislative/LIS/roll_call_lists/roll_call_vote_cfm.cfm?congress=115&session=1&vote=00124
- ↑ McGinley L, Bernstein L, Dawsey J FDA Commissioner Gottlieb, who raised alarms about teen vaping, resigns Washington Post. March 5, 2019 https://www.washingtonpost.com/health/2019/03/05/fda-commissioner-gottlieb-who-raised-alarms-about-teen-vaping-resigns/
- ↑ 3.0 3.1 Physician's First Watch, March 13, 2019 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
Washington Post. Mach 12, 2019 https://www.washingtonpost.com/health/2019/03/12/nations-cancer-chief-appointed-acting-fda-commissioner/?utm_term=.018255b7d249 - ↑ 4.0 4.1 McGinley L Senate confirms oncologist Stephen Hahn as FDA commissioner Washingtom Post. Dec 12, 2019 https://www.washingtonpost.com/health/2019/12/12/senate-confirms-oncologist-stephen-hahn-fda-commissioner/